Genmab — Maj 2018
-
-
-
God morgen.
-
God morgen
-
God morgen
-
God morgen, det sagde vi hele dagen, da jeg var soldat, fordi solen aldrig gik ned
Meget interessant, det pres der er på Genmab, når rest af c25 er i plus på ca.
1 %. -
Man bliver tvunget til at erkende, at en aktie der er skortet af så stor en fond ikke kan stige betydeligt selv ikke på gode nyheder. Den stiger men falder hurtigt tilbage igen. Det ses ALTID lige indtil fonden tvinges til at opgive sine shorts eller bliver tilfreds med gevinsten og lukker. I mellemtiden er der så gode trading muligheder men for den langsigtede er det bare at vente tålmodig, hvis man tror på casen.
-
meanwhile Novartis, receives second FDA approval for their CAR-T - https://www.novartis.com/news/media-releases/kymriahr-tisagenlecleucel-first-class-car-t-therapy-from-novartis-receives-second-fda-approval-treat-appropriate-rr-patients-large-b-cell-lymphoma
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind